Diffuse myocardial fibrosis, but not focal fibrosis identified with delayed enhancement, is an independent predictor of LV reversed remodeling in patients with idiopathic non-ischemic cardiomyopathy

Diffuse myocardial fibrosis, but not focal fibrosis identified with delayed enhancement, is an independent predictor of LV reversed remodeling in patients with idiopathic non-ischemic cardiomyopathy

Bibliographic Details
Main Authors:	Yingchoncharoen Teerapat, Flamm Scott D, Kwon Deborah
Format:	Article
Language:	English
Published:	BMC 2013-01-01
Series:	Journal of Cardiovascular Magnetic Resonance

Similar Items

Interrelationship of LV mass, focal fibrosis by LGE, and diffuse fibrosis by T1-changes in patients with hypertrophic cardiomyopathy
by: Potluri Rahul, et al.
Published: (2012-02-01)

Going beyond ejection fraction - CMR assessment of ventricular-vascular coupling and LV remodeling predicts diastolic dysfunction in advanced ischemic cardiomyopathy
by: Cavalcante Joao L, et al.
Published: (2013-01-01)

Markers of myocardial fibrosis in patients with ischemic cardiomyopathy and atrial fibrillation
by: E I Myasoedova, et al.
Published: (2016-12-01)

Prevalence, predictors and prognosis of ventricular reverse remodeling in idiopathic dilated cardiomyopathy
by: Sandra Amorim, et al.
Published: (2016-05-01)

Prevalence, predictors and prognosis of ventricular reverse remodeling in idiopathic dilated cardiomyopathy
by: Sandra Amorim, et al.
Published: (2016-05-01)

Right ventricular function in dilated cardiomyopathy: relation to location of focal myocardial fibrosis
by: Abdelrazek Mohamed A, et al.
Published: (2013-01-01)

If there is LV myocardial fibrosis should we expect to find RV myocardial fibrosis? A cardiovascular MRI study
by: Biederman Robert W, et al.
Published: (2012-02-01)

Myocardial fibrosis in hypertrophic cardiomyopathy
by: Patel, Vimal
Published: (2018)

Renal Denervation Effects on Myocardial Fibrosis and Ventricular Arrhythmias in Rats with Ischemic Cardiomyopathy
by: Bin Zhang, et al.
Published: (2018-05-01)

High-dose enalapril treatment reverses myocardial fibrosis in experimental uremic cardiomyopathy.
by: Karin Tyralla, et al.
Published: (2011-01-01)

Identification of target genes in cardiomyopathy with fibrosis and cardiac remodeling
by: Jianquan Zhao, et al.
Published: (2018-08-01)

Myocardial fibrosis in desmin-related hypertrophic cardiomyopathy
by: Dai Qinyi, et al.
Published: (2010-11-01)

Predictors of osteopenic syndrome in idiopathic pulmonary fibrosis
by: E A Kochetkova, et al.
Published: (2013-03-01)

Myocardial Fibrosis in the Pathogenesis, Diagnosis, and Treatment of Hypertrophic Cardiomyopathy
by: Zeyi Cheng, et al.
Published: (2021-05-01)

Myocardial Fibrosis in Hypertrophic Cardiomyopathy: What Remains to be Proven?
by: Leonardo Sara

Myocardial fibrosis is a predictor of atrial fibrillation in dilated cardiomyopathy. Role of cardiovascular magnetic resonance
by: Jorge Claudia, et al.
Published: (2011-02-01)

The inter-connection between fibrosis and microvascular remodeling in idiopathic pulmonary fibrosis: Reality or just a phenomenon
by: Mona Mlika, et al.
Published: (2016-01-01)

Focal and diffuse myocardial fibrosis quantification by cardiovascular magnetic resonance
by: Flett, A.
Published: (2012)

Cardiovascular magnetic resonance predictors of heart failure in hypertrophic cardiomyopathy: the role of myocardial replacement fibrosis and the microcirculation
by: Claire E. Raphael, et al.
Published: (2021-03-01)

Myocardial fibrosis reversion via rhACE2-electrospun fibrous patch for ventricular remodeling prevention
by: Zeping Qiu, et al.
Published: (2021-08-01)

Bone Marrow-Derived Multipotent Stromal Cells Promote Myocardial Fibrosis and Reverse Remodeling of the Left Ventricle
by: Timur Fatkhudinov, et al.
Published: (2015-01-01)

MRI determined tissue characterization of myocardial infiltration and fibrosis in cardiomyopathy
by: Ohaji, Chimela Tobechi
Published: (2018)

Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis
by: Gavin Tjin, et al.
Published: (2017-11-01)

Effect of sarcomere and mitochondria-related mutations on myocardial fibrosis in patients with hypertrophic cardiomyopathy
by: Hyemoon Chung, et al.
Published: (2021-03-01)

End systolic volume and scar burden are incremental and independent predictors of survival in patients with severe ischemic cardiomyopathy
by: Kwon Deborah, et al.
Published: (2012-02-01)

Myocardial fibrosis — a new component of heart remodeling in athletes?
by: A. S. Sharykin, et al.
Published: (2019-12-01)

Yes-Associated Protein is Involved in Myocardial Fibrosis in Rats with Diabetic Cardiomyopathy
by: Hu M, et al.
Published: (2021-05-01)

Magnetic Resonance Imaging in Myocardial Fibrosis Related to Ischemic Events
by: Himcinschi Elisabeta, et al.
Published: (2017-09-01)

Idiopathic pulmonary fibrosis
by: Noble Paul W, et al.
Published: (2008-03-01)

Idiopathic Pulmonary Fibrosis
Published: (2022)

Galectin 3 and non-classical monocytes of blood as myocardial remodeling factors at ischemic cardiomyopathy
by: S. Chumakova, et al.
Published: (2021-04-01)

Non-ischemic cardiomyopathy with focal segmental glomerulosclerosis
by: Parminder Kaur, et al.
Published: (2020-03-01)

Adropin Alleviates Myocardial Fibrosis in Diabetic Cardiomyopathy Rats: A Preliminary Study
by: Mao Liu, et al.
Published: (2021-07-01)

Genotype-Related Clinical Characteristics and Myocardial Fibrosis and their Association with Prognosis in Hypertrophic Cardiomyopathy
by: Hyung Yoon Kim, et al.
Published: (2020-06-01)

Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy using cardiovascular magnetic resonance
by: Burke Margaret, et al.
Published: (2010-01-01)

Comment on «Progression of myocardial fibrosis assessed with cardiac magnetic resonance in hypertrophic cardiomyopathy»
by: Ana G. Almeida
Published: (2012-11-01)

Association of LA volumes and mid-wall myocardial fibrosis in the Dilated cardiomyopathy patients
by: Mohiaddin Raad, et al.
Published: (2011-02-01)

Myocardial fibrosis is not associated with reduced quality of life in patients with dilated or hypertrophic cardiomyopathy
by: Drangova Maria, et al.
Published: (2011-02-01)

Diffuse fibrosis in dilated cardiomyopathy results in a shorter myocardial null time
by: Manning Warren J, et al.
Published: (2009-01-01)

Myocardial remodelling and recovery in dilated cardiomyopathy
by: Upasana Tayal, et al.
Published: (2017-10-01)

Cannot write session to /tmp/vufind_sessions/sess_e57qko3964btadsdhug0fbink3